Despite high expectations for a commonly used erectile dysfunction drug to treat patients with diastolic heart failure, no beneficial effects were found in a study presented today at the American College of Cardiology's 62nd ...
Mar 12, 2013
0
0
Among patients with heart failure with preserved ejection fraction (a measure of heart function), administration of sildenafil (commercially known as Viagra) for 24 weeks, compared with placebo, did not result in significant ...
Mar 11, 2013
0
0
In a study of mice, researchers at Johns Hopkins have identified a new molecular pathway involved in the growth of tiny air sacs called alveoli that are crucial for breathing. The scientists say their experiments may lead ...
Feb 14, 2013
0
0
For patients with medically operable clinical stage I non–small-cell lung cancer (NSCLC), lobectomy or pneumonectomy is the standard approach. For patients with medically inoperable stage I NSCLC, stereotactic body radiotherapy ...
Jan 15, 2013
0
0
(Medical Xpress)—Impairment of a key signaling cascade in the pulmonary blood vessels plays an important role in pulmonary arterial hypertension, a Yale study has found. The study appears in the advance online publication ...
Dec 27, 2012
0
0
(HealthDay)—In children with type 3 osteogenesis imperfecta (OI) and thoracic insufficiency syndrome (TIS), thoracic elongation surgery using a novel expandable spino-thoracic fixation device significantly improves pulmonary ...
Nov 20, 2012
0
0
A study suggests that diagnostic tests are frequently repeated among Medicare beneficiaries, according to a report published Online First by Archives of Internal Medicine.
Nov 19, 2012
0
0
Researchers from the Universities of Nottingham and Leicester are leading the largest ever study of the genetics relating to lung disease.
Nov 14, 2012
0
0
(HealthDay)—For older adults with chronic obstructive pulmonary disease (COPD), the likelihood of carotid artery thickening is increased and vulnerable lipid core plaques are more frequent than in controls with normal lung ...
Nov 12, 2012
0
1
Roflumilast was associated with significant improvements in lung function in patients with moderate and severe chronic obstructive pulmonary disease (COPD) after 6 months of treatment compared with placebo.
Oct 22, 2012
0
0
